Impact of cigarette smoking on outcome of hepatocellular carcinoma after surgery in patients with hepatitis B.

BACKGROUND AND OBJECTIVES: Cigarette smoking is a potential risk factor for hepatocellular carcinoma (HCC) initiation, partially through interaction with hepatitis B virus (HBV). We examined the hypothesis that cigarette smoking might be associated with HBV-related HCC recurrence and patient surviva...

Full description

Bibliographic Details
Main Authors: Xu-Feng Zhang, Tao Wei, Xue-Min Liu, Chang Liu, Yi Lv
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3893178?pdf=render
_version_ 1811216275695730688
author Xu-Feng Zhang
Tao Wei
Xue-Min Liu
Chang Liu
Yi Lv
author_facet Xu-Feng Zhang
Tao Wei
Xue-Min Liu
Chang Liu
Yi Lv
author_sort Xu-Feng Zhang
collection DOAJ
description BACKGROUND AND OBJECTIVES: Cigarette smoking is a potential risk factor for hepatocellular carcinoma (HCC) initiation, partially through interaction with hepatitis B virus (HBV). We examined the hypothesis that cigarette smoking might be associated with HBV-related HCC recurrence and patient survival after curative surgery. PATIENTS AND METHODS: Data of 302 patients with HBV infection who had undergone curative resection for HCC were prospectively collected from 2008 to 2011. Smoking status and smoking quantity (pack-years, PY) were asked at admission. Factors affecting recurrence-free survival (RFS) were examined. RFS and liver-specific mortality (LSM) stratified by risk factors were compared with log-rank test. RESULTS: 109 were current smokers. Current smokers were not different from non-smokers in tumor burden and surgical procedure. Univariate and multivariate analysis identified that heavy smoking (PY ≥ 20) was the most significant factor associated with HBV-related HCC recurrence after curative surgical resection (p = 0.001), followed by anti-HBV treatment (p<0.01), current smoking (p = 0.028), surgical margin <1 cm (p = 0.048) and blood transfusion >600 ml (p = 0.028). The median RFS in non-smokers, ex-smokers and current smokers was 34 months, 24 months and 26 months, respectively (p = 0.033). Current smokers had significantly worse RFS rate and increased 5-year cumulative LSM than non-smokers (p = 0.024, and p<0.001, respectively). Heavy smokers had significantly worse RFS than non- and light smokers (0<PY<20) (p<0.001, respectively) and higher cumulative LSM than non-smokers and light smokers (p = 0.003 and 0.001, respectively). Furthermore, in current smokers, continuing smoking postoperatively was strongly associated with poorer RFS and higher LSM than those who quit smoking postoperatively (p = 0.016 and p = 0.003, respectively). CONCLUSIONS: Smoking history and quantity appears to be risk factors for HBV-related HCC recurrence and LSM of patients after surgery. For smokers, continued smoking postoperatively might accelerate tumor recurrence and patient death. Therefore, smoking abstinence should be strongly recommended to patients pre- and postoperatively.
first_indexed 2024-04-12T06:36:42Z
format Article
id doaj.art-26a3f19581d7477fa3349402a27727af
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T06:36:42Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-26a3f19581d7477fa3349402a27727af2022-12-22T03:43:51ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0191e8507710.1371/journal.pone.0085077Impact of cigarette smoking on outcome of hepatocellular carcinoma after surgery in patients with hepatitis B.Xu-Feng ZhangTao WeiXue-Min LiuChang LiuYi LvBACKGROUND AND OBJECTIVES: Cigarette smoking is a potential risk factor for hepatocellular carcinoma (HCC) initiation, partially through interaction with hepatitis B virus (HBV). We examined the hypothesis that cigarette smoking might be associated with HBV-related HCC recurrence and patient survival after curative surgery. PATIENTS AND METHODS: Data of 302 patients with HBV infection who had undergone curative resection for HCC were prospectively collected from 2008 to 2011. Smoking status and smoking quantity (pack-years, PY) were asked at admission. Factors affecting recurrence-free survival (RFS) were examined. RFS and liver-specific mortality (LSM) stratified by risk factors were compared with log-rank test. RESULTS: 109 were current smokers. Current smokers were not different from non-smokers in tumor burden and surgical procedure. Univariate and multivariate analysis identified that heavy smoking (PY ≥ 20) was the most significant factor associated with HBV-related HCC recurrence after curative surgical resection (p = 0.001), followed by anti-HBV treatment (p<0.01), current smoking (p = 0.028), surgical margin <1 cm (p = 0.048) and blood transfusion >600 ml (p = 0.028). The median RFS in non-smokers, ex-smokers and current smokers was 34 months, 24 months and 26 months, respectively (p = 0.033). Current smokers had significantly worse RFS rate and increased 5-year cumulative LSM than non-smokers (p = 0.024, and p<0.001, respectively). Heavy smokers had significantly worse RFS than non- and light smokers (0<PY<20) (p<0.001, respectively) and higher cumulative LSM than non-smokers and light smokers (p = 0.003 and 0.001, respectively). Furthermore, in current smokers, continuing smoking postoperatively was strongly associated with poorer RFS and higher LSM than those who quit smoking postoperatively (p = 0.016 and p = 0.003, respectively). CONCLUSIONS: Smoking history and quantity appears to be risk factors for HBV-related HCC recurrence and LSM of patients after surgery. For smokers, continued smoking postoperatively might accelerate tumor recurrence and patient death. Therefore, smoking abstinence should be strongly recommended to patients pre- and postoperatively.http://europepmc.org/articles/PMC3893178?pdf=render
spellingShingle Xu-Feng Zhang
Tao Wei
Xue-Min Liu
Chang Liu
Yi Lv
Impact of cigarette smoking on outcome of hepatocellular carcinoma after surgery in patients with hepatitis B.
PLoS ONE
title Impact of cigarette smoking on outcome of hepatocellular carcinoma after surgery in patients with hepatitis B.
title_full Impact of cigarette smoking on outcome of hepatocellular carcinoma after surgery in patients with hepatitis B.
title_fullStr Impact of cigarette smoking on outcome of hepatocellular carcinoma after surgery in patients with hepatitis B.
title_full_unstemmed Impact of cigarette smoking on outcome of hepatocellular carcinoma after surgery in patients with hepatitis B.
title_short Impact of cigarette smoking on outcome of hepatocellular carcinoma after surgery in patients with hepatitis B.
title_sort impact of cigarette smoking on outcome of hepatocellular carcinoma after surgery in patients with hepatitis b
url http://europepmc.org/articles/PMC3893178?pdf=render
work_keys_str_mv AT xufengzhang impactofcigarettesmokingonoutcomeofhepatocellularcarcinomaaftersurgeryinpatientswithhepatitisb
AT taowei impactofcigarettesmokingonoutcomeofhepatocellularcarcinomaaftersurgeryinpatientswithhepatitisb
AT xueminliu impactofcigarettesmokingonoutcomeofhepatocellularcarcinomaaftersurgeryinpatientswithhepatitisb
AT changliu impactofcigarettesmokingonoutcomeofhepatocellularcarcinomaaftersurgeryinpatientswithhepatitisb
AT yilv impactofcigarettesmokingonoutcomeofhepatocellularcarcinomaaftersurgeryinpatientswithhepatitisb